국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
Fenbendazole
Intervet Ireland Limited
QP52AC13
Fenbendazole
10 percent weight/volume
Oral suspension
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Horses
fenbendazole
Endoparasiticide
Authorised
1999-10-01
Health Products Regulatory Authority 26 October 2017 CRN000WL0 Page 1 of 6 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Panacur 10 % w/v Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains ACTIVE SUBSTANCE Fenbendazole 100 mg EXCIPIENTS Sodium Methyl Parahydroxybenzoate 2.000 mg Sodium Propyl Parahydroxybenzoate 0.216 mg Benzyl alcohol 4.835 mg For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses and cattle 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of immature and mature stages of nematodes of the gastro-intestinal and respiratory tracts of cattle and horses including encysted mucosal small redworm larvae in horses. Panacur has an ovicidal effect on roundworm eggs. Also effective against cestodes in cattle. For the treatment of horses infected with adult large strongyles and adult and larval small strongyles. Also controls ascarids and oxyurids species. For the treatment of cattle infected with adult and immature stages of: _Haemonchus _spp., _Ostertagia _spp., _Trichostrongylus _spp., _Cooperia _spp., _Nematodirus _ spp., _Bunostomum _spp., _Trichuris _spp., _Strongyloides _spp., _Oesophagostomum _spp., _Capillaria _spp., _Dictyocaulus _spp. Used at the recommended dose and time, Panacur is effective against inhibited larvae of _Ostertagia _spp. and against _Moniezia _spp. of tapeworm. Health Products Regulatory Authority 26 October 2017 CRN000WL0 Page 2 of 6 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: • Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. • Underdosing, which may be due to underestimation of body weight, misadmi 전체 문서 읽기